Goldman Sachs’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.1M | Buy |
|
|||||
|
2025
Q1 | $35.1M | Sell |
|
|||||
|
2024
Q4 | $46.3M | Buy |
|
|||||
|
2024
Q3 | $52.2M | Buy |
|
|||||
|
2024
Q2 | $11.6M | Buy |
|
|||||
|
2024
Q1 | $5.97M | Sell |
|
|||||
|
2023
Q4 | $7.83M | Sell |
|
|||||
|
2023
Q3 | $8.05M | Buy |
|
|||||
|
2023
Q2 | $3.96M | Buy |
|
|||||
|
2023
Q1 | $3.15M | Buy |
|
|||||
|
2022
Q4 | $3.39M | Buy |
|
|||||
|
2022
Q3 | $1.51M | Buy |
|
|||||
|
2022
Q2 | $881K | Sell |
|
|||||
|
2022
Q1 | $1.23M | Buy |
|
|||||
|
2021
Q4 | $220K | Sell |
|
|||||
|
2021
Q3 | $270K | Buy |
|
|||||
|
2021
Q2 | $229K | Sell |
|
|||||
|
2021
Q1 | $661K | Buy |
|
|||||
|
2020
Q4 | $524K | Sell |
|
|||||
|
2020
Q3 | $1.42M | Buy |
|
|||||
|
2020
Q2 | $1.75M | Buy |
|
|||||
|
2020
Q1 | $1.42M | Buy |
|
|||||
|
2019
Q4 | $1.41M | Buy |
|
|||||
|
2019
Q3 | $564K | Buy |
|
|||||
|
2019
Q2 | $75K | Sell |
|
|||||
|
2019
Q1 | $81K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $204K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $429K | Buy |
|
|||||
|
2017
Q4 | $98K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $107K | Sell |
|
|||||
|
2015
Q3 | $114K | Buy |
|
|||||
|
2015
Q2 | $120K | Sell |
|
|||||
|
2015
Q1 | $151K | Buy |
|